Interestingly, the combination of the β-F1-ATPase/LDH-A ratio with the expression of myophosphorylase (PYGM) allows the discrimination of DMD patients with 100% of sensitivity (Table 2). This evidence concerns the gene LDHA and Duchenne muscular dystrophy.